Stay updated on Ligelizumab in CSU Japanese Patients Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.

Latest updates to the Ligelizumab in CSU Japanese Patients Clinical Trial page
- Check3 days agoChange DetectedAdded a site-wide notice about government funding lapse and open status, directing users to cc.nih.gov and opm.gov. Updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check10 days agoChange DetectedCosmetic updates include adding a 'Show glossary' option, capitalization tweaks for QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria'), a new 'No FEAR Act Data' label, and revision tag 'v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page shows a minor revision update: v3.3.4 replaces v3.3.3, with no changes to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded a consolidated Locations section listing sites in Chiba, Hokkaido, Hyōgo, Kanagawa, Osaka, and Tokyo, and removed the separate per-location subheadings (Chiba Locations, Hokkaido Locations, Hyōgo Locations, Kanagawa Locations, Osaka Locations, Tokyo Locations). Revision updated to v3.3.3.SummaryDifference0.7%

- Check74 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 in the page header. No substantive content changes to study details or eligibility criteria are evident from the visible page content.SummaryDifference0.1%

- Check81 days agoChange DetectedRemoved the government funding/status notice; this informational banner did not impact study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ligelizumab in CSU Japanese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.